GO:0070241 positive regulation of activated T cell autonomous cell death: Apoptosis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070241 describes any process that increases the frequency, rate or extent of activated T cell autonomous cell death, a cell-intrinsic apoptosis program triggered after T cell activation.
• The term is a biological_process child of the broader regulation of activated T cell autonomous cell death and is mechanistically distinct from extrinsic, receptor-mediated T cell killing.
• Glucocorticoid metabolism, caspase-8 signaling, mitochondrial arginase-2, CARD11 signaling and cytokine cues such as TL1A are established cell-autonomous regulators of activated T cell fate.
• Loss of cell-autonomous death checkpoints causes activated T cell hyperaccumulation, autoimmunity and persistent inflammation, whereas excessive death impairs antiviral and antitumor immunity.
• Key experimental systems include conditional knockout mice, point-mutation knock-ins, reporter knock-ins, overexpression lines and CRISPR library screens in primary and transformed T cells.
• EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models and CRISPR library screening with bioinformatics to dissect GO:0070241 regulators.
Description
GO:0070241, positive regulation of activated T cell autonomous cell death, is a Gene Ontology biological_process term that captures any process which activates or increases the frequency, rate or extent of activated T cell autonomous cell death. In practical terms, it describes the cell-intrinsic suicide program that an already activated T lymphocyte runs after it has responded to antigen, a program that is essential for contracting immune responses and preventing accumulation of autoreactive or persistently activated T cells. The term is deliberately narrower than generic apoptosis: it requires that the dying cell is an activated T cell and that the death is autonomous, meaning the fate is decided within the T cell itself rather than imposed by an external cytotoxic effector. Researchers care about GO:0070241 because it sits at the intersection of immune tolerance, autoimmunity, chronic infection and cancer immunology. When positive regulation of activated T cell autonomous cell death fails, activated T cells can hyperaccumulate and drive immunopathology, as shown for CARD11 gain-of-function mutations that produce cell-autonomous accumulation of PD-1-positive ICOS-high activated T cells and T follicular regulatory cells. Conversely, when this death program is too efficient, antiviral CD8 T cell responses contract prematurely, a phenotype observed when caspase-8 is absent and antiviral CD8 T cells hyperaccumulate because normal restriction is lost. The term also matters for immunotherapy and inflammatory disease research. Tumor necrosis factor-like cytokine 1A contributes to inflammatory bowel disease pathogenesis and influences T cell activation and death decisions, while mitochondrial arginase-2 acts as a cell-autonomous regulator of CD8 T cell function and antitumor efficacy. Because the process is cell-intrinsic, it is highly amenable to genetic dissection with CRISPR knockout, point mutation, knock-in and overexpression models, making GO:0070241 a tractable target for mechanistic and translational studies.
positive regulation of activated T cell autonomous cell death At A Glance
| GO ID | GO:0070241 |
|---|---|
| GO term | positive regulation of activated T cell autonomous cell death |
| Ontology | biological_process |
| Synonym | positive regulation of activated T cell apoptosis; positive regulation of ACAD; up regulation of activated T cell autonomous cell death |
| Major function | Increases the frequency, rate or extent of cell-intrinsic death of activated T cells |
| Biological context | Contraction of T cell responses, immune tolerance, resolution of inflammation |
| Cellular location | Activated T lymphocyte, with mitochondrial and caspase-dependent signaling involved |
| Related process | Regulation of activated T cell autonomous cell death; apoptotic process |
| Disease relevance | Autoimmunity, inflammatory bowel disease, chronic viral infection, cancer immunity |
What Is GO:0070241?
In plain language, GO:0070241 means any biological activity that pushes an activated T cell to die by its own internal death program. The QuickGO definition states: any process that activates or increases the frequency, rate or extent of activated T cell autonomous cell death. The term is a biological_process and is the positive-regulation counterpart of the regulation of activated T cell autonomous cell death. Its many synonyms, including positive regulation of activated T cell apoptosis and positive regulation of ACAD, all refer to the same concept: enhancing the intrinsic death of T cells that have already been activated. Crucially, the term excludes death imposed by external cytotoxic cells and focuses on signals, metabolites and signaling proteins that act within the activated T cell to promote its own demise.
Why Is positive regulation of activated T cell autonomous cell death Important in Cell Biology?
GO:0070241 is important because the decision of an activated T cell to die autonomously determines the size and duration of an immune response. Positive regulation of this death program is required to contract effector populations after antigen clearance and to eliminate activated T cells that could otherwise sustain autoimmunity or chronic inflammation. At the same time, the process must be tightly restrained during active infection and antitumor immunity, because premature autonomous death of activated CD8 T cells weakens pathogen control and tumor rejection. Understanding which genes positively regulate this process, and how, therefore has direct implications for autoimmune disease, inflammatory bowel disease, antiviral immunity and cancer immunotherapy.
• Controls contraction of activated T cell populations after antigen clearance.
• Prevents cell-autonomous accumulation of activated T cells that can drive autoimmunity.
• Shapes inflammatory bowel disease pathogenesis through cytokine and T cell death crosstalk.
• Regulates CD8 T cell function and antitumor efficacy via mitochondrial metabolism.
• Restricts antiviral CD8 T cell hyperaccumulation through caspase-8-dependent mechanisms.
• Influences T cell tolerance induction in the liver microenvironment.
• Modulates cytotoxic T cell trafficking and exclusion in tumors.
• Links cancer cell death pathways to licensing of CD8 T cell immunity.
• Provides a genetically tractable process for CRISPR knockout, knock-in and overexpression studies.
• Offers candidate targets for modulating immune response duration in immunotherapy.
What Happens During positive regulation of activated T cell autonomous cell death?
Activation-induced sensitization of T cells to autonomous death
In simple terms: Once a T cell is activated, it becomes primed to die by its own internal program unless survival signals keep it alive.
Positive regulation of activated T cell autonomous cell death begins with T cell activation, which reprograms the cell so that intrinsic death pathways become responsive to pro-death signals. In this sensitized state, cell-autonomous regulators such as mitochondrial arginase-2 can modulate CD8 T cell function and survival, thereby influencing whether activated cells persist or die. Similarly, cytokine cues such as tumor necrosis factor-like cytokine 1A participate in inflammatory settings and can shape T cell activation and death decisions relevant to inflammatory bowel disease. The sensitization step is therefore the context in which positive regulators of GO:0070241 act.
Metabolic and mitochondrial control of activated T cell fate
In simple terms: Mitochondria and their metabolic enzymes act as internal switches that help decide whether an activated T cell lives or dies.
Mitochondrial arginase-2 is a cell-autonomous regulator of CD8 T cell function and antitumor efficacy, showing that mitochondrial metabolism directly influences the fate of activated T cells. Because positive regulation of activated T cell autonomous cell death requires intracellular decision-making, metabolic enzymes that tune mitochondrial state are positioned to promote or restrain this process. This step links GO:0070241 to immunometabolism and to the survival of tumor-infiltrating T cells.
Caspase-dependent restriction of activated T cell accumulation
In simple terms: Caspase-8 acts as a brake that prevents activated antiviral T cells from piling up.
Caspase-8 restricts antiviral CD8 T cell hyperaccumulation, demonstrating that caspase-dependent signaling is a positive regulator of autonomous death in activated T cells. When this restriction is lost, activated CD8 T cells accumulate abnormally, which illustrates how positive regulation of GO:0070241 normally limits the size of activated T cell pools. This step places caspase-8 among the core effectors that execute or enable activated T cell autonomous death.
Glucocorticoid metabolite regeneration as an intrinsic death trigger
In simple terms: T cells can regenerate inert glucocorticoid metabolites into active steroids that then push the cell toward death.
T-cell autonomous death can be induced by regeneration of inert glucocorticoid metabolites, a mechanism in which the activated T cell itself converts inactive precursors into active glucocorticoids that promote its own death. This finding directly supports the concept of positive regulation of activated T cell autonomous cell death because the pro-death signal is generated within the T cell rather than delivered by an external endocrine source. It also provides a mechanistic example of how intracellular metabolism can positively regulate GO:0070241.
Signaling thresholds set by CARD11 and costimulatory receptors
In simple terms: Signals through CARD11 and receptors such as PD-1 and ICOS set the threshold at which activated T cells accumulate or die.
CARD11 gain-of-function mutation drives cell-autonomous accumulation of PD-1-positive ICOS-high activated T cells, T follicular, T regulatory and T follicular regulatory cells, indicating that CARD11 signaling thresholds control whether activated T cells persist. This observation implies that normal CARD11 signaling contributes to setting the balance in which positive regulation of activated T cell autonomous cell death can proceed. Dysregulated signaling therefore shifts the balance away from autonomous death and toward accumulation.
Microenvironmental modulation of autonomous death
In simple terms: The tissue environment, such as the liver or a tumor, can tune how readily activated T cells die on their own.
Liver sinusoidal endothelial cells dynamically regulate CD8 T cell tolerance induction, showing that tissue microenvironments can shape the fate of activated T cells. In tumors, Plexin-A4 mediates cytotoxic T cell trafficking and exclusion, which indirectly affects whether activated T cells persist or are lost from the tumor bed. Additionally, tumoral AMER1-driven dopamine synthesis triggers cancer cell pyroptosis and licenses CD8 T cell immunity in colorectal cancer, linking tumor cell death to the activation state of CD8 T cells. These contexts illustrate that positive regulation of GO:0070241 operates within, and is modulated by, the surrounding tissue environment.
Key Genes Involved in GO:0070241 positive regulation of activated T cell autonomous cell death
The following genes and proteins have been experimentally linked to cell-autonomous regulation of activated T cell survival, death or accumulation and are therefore relevant to GO:0070241.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CASP8 | Caspase-8 restricts antiviral CD8 T cell hyperaccumulation | Core effector of autonomous death restriction in activated T cells |
| CARD11 | Gain-of-function drives cell-autonomous accumulation of activated T cells | Signaling threshold controlling activated T cell persistence |
| ARG2 | Mitochondrial arginase-2 is a cell-autonomous regulator of CD8 T cell function | Links mitochondrial metabolism to activated T cell fate |
| TL1A (TNFSF15) | Tumor necrosis factor-like cytokine 1A in inflammatory bowel disease pathogenesis | Cytokine cue influencing T cell activation and death |
| PDCD1 (PD-1) | Marker of accumulated activated T cells in CARD11 gain-of-function | Readout of failed autonomous death |
| ICOS | ICOS-high activated T cell phenotype in CARD11 gain-of-function | Costimulatory marker of persistent activated T cells |
| PLXNA4 | Plexin-A4 mediates cytotoxic T cell trafficking and exclusion in cancer | Microenvironmental control of T cell persistence |
| AMER1 | Tumoral AMER1-driven dopamine synthesis licenses CD8 T cell immunity | Links tumor cell death to CD8 T cell activation |
| NR3C1 (GR) | Glucocorticoid receptor mediates steroid-induced death signals | Target of regenerated glucocorticoid metabolites in T cells |
| HSD11B | Enzymes that interconvert inert and active glucocorticoids | Candidate mediators of T-cell autonomous steroid regeneration |
| BCL2L11 (BIM) | Pro-apoptotic BCL-2 family member in T cell death | Candidate intrinsic apoptosis effector in activated T cells |
| BCL2 | Anti-apoptotic guardian of T cell survival | Counterbalance to positive regulation of autonomous death |
| FAS | Death receptor contributing to activation-induced T cell death | Context-dependent regulator of activated T cell fate |
| IL2 | Growth factor supporting activated T cell survival | Opposes autonomous death after activation |
| FOXP3 | Regulatory T cell lineage factor affected in CARD11 gain-of-function | Links autonomous death pathways to tolerance |
| CD8A | Defines cytotoxic T cells studied in autonomous death models | Cell type context for GO:0070241 |
| CD4 | Defines helper T cells studied in autonomous death models | Cell type context for GO:0070241 |
How Is positive regulation of activated T cell autonomous cell death Regulated?
Positive regulation of activated T cell autonomous cell death is controlled by an interplay of intracellular signaling thresholds, metabolic state and cytokine cues. CARD11 signaling sets a threshold for activated T cell accumulation, and gain-of-function mutation shifts cells toward persistence rather than autonomous death. Mitochondrial arginase-2 acts cell-autonomously to regulate CD8 T cell function, indicating that mitochondrial metabolism tunes the sensitivity of activated T cells to death. Caspase-8 provides a restriction point that prevents antiviral CD8 T cell hyperaccumulation, so its activity is a positive regulator of the process. Glucocorticoid metabolism adds a steroid-based layer, because activated T cells can regenerate inert glucocorticoid metabolites into active steroids that induce their own death. Finally, tissue microenvironments such as liver sinusoids and tumors modulate these intrinsic programs through tolerance induction and trafficking signals.
positive regulation of activated T cell autonomous cell death and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CARD11 | Autoimmunity and immune dysregulation with activated T cell accumulation | CARD11 gain-of-function knock-in T cell model |
| CASP8 | Antiviral CD8 T cell hyperaccumulation | Conditional Casp8 knockout in CD8 T cells |
| ARG2 | CD8 T cell function and antitumor efficacy | Arg2 knockout or overexpression in CD8 T cells |
| TL1A (TNFSF15) | Inflammatory bowel disease pathogenesis | TL1A knockout or overexpression in colitis models |
| PLXNA4 | Cytotoxic T cell trafficking and exclusion in cancer | Plxna4 knockout in tumor models |
Autoimmunity and immune dysregulation
When positive regulation of activated T cell autonomous cell death is impaired, activated T cells can accumulate in a cell-autonomous manner. CARD11 gain-of-function mutation drives cell-autonomous accumulation of PD-1-positive ICOS-high activated T cells, T follicular, T regulatory and T follicular regulatory cells, a setting that can promote immune dysregulation and autoimmunity. This illustrates how failure of GO:0070241 contributes to persistent activated T cell populations.
Inflammatory bowel disease
Tumor necrosis factor-like cytokine 1A plays a role in inflammatory bowel disease pathogenesis, and this cytokine influences T cell activation and death decisions in the inflamed gut. Because GO:0070241 governs the autonomous death of activated T cells, altered regulation of this process may contribute to the persistence of activated T cells in inflammatory bowel disease.
Antiviral immunity and T cell hyperaccumulation
Caspase-8 restricts antiviral CD8 T cell hyperaccumulation, so loss of this positive regulator of autonomous death leads to excessive accumulation of activated antiviral T cells. This links GO:0070241 to the control of antiviral immune responses and to the risk of immunopathology when the death program is defective.
Cancer immunity and immunotherapy
Mitochondrial arginase-2 is a cell-autonomous regulator of CD8 T cell function and antitumor efficacy, tying GO:0070241 to the survival of tumor-reactive T cells. Plexin-A4 mediates cytotoxic T cell trafficking and exclusion in cancer, affecting whether activated T cells reach and persist in tumors. In colorectal cancer, tumoral AMER1-driven dopamine synthesis triggers cancer cell pyroptosis and licenses CD8 T cell immunity, showing that tumor cell death pathways can influence CD8 T cell activation states relevant to this process.
From positive regulation of activated T cell autonomous cell death-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for activated T cell autonomous death? | CRISPR knockout in primary or transformed T cells |
| Does a specific point mutation alter the death threshold? | Point-mutation knock-in at the endogenous locus |
| Does a candidate gene promote autonomous death when overexpressed? | Overexpression cell model in activated T cells |
| Where and when is the gene product expressed during activation? | Tagged knock-in with reporter or epitope tag |
| Which genes positively regulate the process genome-wide? | CRISPR library screening with bioinformatics |
| How does the tissue microenvironment modulate autonomous death? | Coculture with liver sinusoidal endothelial cells or tumor cells |
How to Study the positive regulation of activated T cell autonomous cell death Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effect on activated T cell death | Testing requirement of candidate genes |
| Point-mutation knock-in | Effect of a specific variant on death threshold | Modeling gain-of-function or loss-of-function alleles |
| Overexpression | Sufficiency of a gene to promote autonomous death | Testing pro-death activity of candidates |
| Flow cytometry | Activated T cell numbers and surface markers | Quantifying PD-1-positive ICOS-high accumulation |
| Viability and apoptosis assays | Frequency of dying activated T cells | Measuring autonomous death rates |
| Metabolic profiling | Mitochondrial and metabolic state | Linking metabolism to T cell fate |
| In vivo infection models | Antiviral CD8 T cell accumulation | Testing restriction of hyperaccumulation |
| Tumor models | T cell infiltration, exclusion and efficacy | Assessing antitumor immunity |
Genetic perturbation with CRISPR
CRISPR knockout, point-mutation knock-in and overexpression models allow direct testing of whether a candidate gene positively regulates activated T cell autonomous cell death. For example, caspase-8 restriction of antiviral CD8 T cell hyperaccumulation was demonstrated through genetic loss-of-function approaches, and CARD11 gain-of-function was modeled to show cell-autonomous accumulation of activated T cells. These strategies are central to assigning genes to GO:0070241.
Flow cytometry and viability assays
Flow cytometry can quantify activated T cell numbers, surface markers such as PD-1 and ICOS, and viability after activation. The CARD11 gain-of-function phenotype was defined by accumulation of PD-1-positive ICOS-high activated T cells, illustrating how marker-based flow analysis reports on failed autonomous death. Similar readouts are used to assess caspase-8-dependent restriction of CD8 T cell hyperaccumulation.
Metabolic and mitochondrial profiling
Because mitochondrial arginase-2 acts cell-autonomously to regulate CD8 T cell function, metabolic profiling and mitochondrial assays are useful for studying GO:0070241. Such methods connect the death decision to immunometabolism and can reveal how metabolic enzymes tune activated T cell fate.
In vivo disease and tumor models
Inflammatory bowel disease models, antiviral infection models and tumor models provide physiological contexts for GO:0070241. TL1A has been studied in inflammatory bowel disease pathogenesis, caspase-8 in antiviral CD8 T cell responses, and arginase-2 in antitumor efficacy. Tumor models also allow assessment of T cell trafficking and exclusion mediated by Plexin-A4 and of CD8 T cell immunity linked to AMER1-driven tumor cell pyroptosis.
How CRISPR Can Be Used to Study GO:0070241 positive regulation of activated T cell autonomous cell death
Knockout
CRISPR knockout is used to remove a candidate positive regulator and test whether activated T cells then fail to die autonomously. This approach is exemplified by studies showing that loss of caspase-8 leads to antiviral CD8 T cell hyperaccumulation, indicating that caspase-8 normally restricts activated T cell accumulation. Knockout models are therefore a primary tool for assigning genes to GO:0070241.
Point Mutation
Point-mutation knock-in allows precise modeling of disease-associated or signaling variants. CARD11 gain-of-function mutation drives cell-autonomous accumulation of PD-1-positive ICOS-high activated T cells, demonstrating how a single signaling change can shift the balance away from autonomous death. Such models are valuable for dissecting how specific residues control positive regulation of activated T cell autonomous cell death.
Knock-in
Tagged or reporter knock-in can be used to track expression and localization of genes involved in activated T cell autonomous death. Because glucocorticoid metabolite regeneration within T cells induces autonomous death, knock-in reporters for the relevant metabolic enzymes can reveal when and where the pro-death signal is generated. Knock-in approaches thus complement functional assays for GO:0070241.
Overexpression
Overexpression models test whether a candidate gene is sufficient to promote activated T cell autonomous death. Mitochondrial arginase-2 is a cell-autonomous regulator of CD8 T cell function and antitumor efficacy, and overexpression or metabolic manipulation can reveal its impact on T cell fate. Overexpression is therefore a complementary strategy to knockout for defining positive regulators in GO:0070241.
How EDITGENE Supports positive regulation of activated T cell autonomous cell death Research
Researchers studying positive regulation of activated T cell autonomous cell death-related genes often need to determine whether a candidate gene is causally involved in the death decision, whether a specific variant alters the threshold, and whether the gene is sufficient to drive autonomous death. Answering these questions requires precise genetic models in relevant T cell contexts, combined with functional readouts such as viability, marker expression and in vivo immune challenge.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of activated T cell autonomous cell death research.
Frequently Asked Questions About positive regulation of activated T cell autonomous cell death
What is GO:0070241?
GO:0070241 is the Gene Ontology biological_process term positive regulation of activated T cell autonomous cell death, defined as any process that activates or increases the frequency, rate or extent of activated T cell autonomous cell death.
What does positive regulation of activated T cell autonomous cell death mean?
It means enhancing the cell-intrinsic death program of T cells that have already been activated, so that they die by their own internal machinery rather than through an external killer.
What genes are involved in positive regulation of activated T cell autonomous cell death?
Genes with experimental links include CASP8, CARD11, ARG2, TL1A (TNFSF15), PDCD1, ICOS, PLXNA4 and AMER1, among others.
How is activated T cell autonomous cell death different from general apoptosis?
It is restricted to activated T cells and requires that the death decision is cell-autonomous, meaning it is made within the T cell itself rather than imposed by an external cytotoxic cell.
Why is caspase-8 important for activated T cell autonomous death?
Caspase-8 restricts antiviral CD8 T cell hyperaccumulation, so its activity is a positive regulator that prevents excessive accumulation of activated T cells.
What role does CARD11 play in activated T cell accumulation?
CARD11 gain-of-function mutation drives cell-autonomous accumulation of PD-1-positive ICOS-high activated T cells and related subsets, showing that CARD11 signaling thresholds control activated T cell persistence.
How does metabolism influence activated T cell autonomous death?
Mitochondrial arginase-2 is a cell-autonomous regulator of CD8 T cell function and antitumor efficacy, indicating that mitochondrial metabolism tunes the fate of activated T cells.
Which diseases are linked to defects in this process?
Defects have been linked to autoimmunity and immune dysregulation, inflammatory bowel disease, antiviral CD8 T cell hyperaccumulation and altered cancer immunity.
How can researchers study GO:0070241 experimentally?
Common approaches include CRISPR knockout, point-mutation knock-in, overexpression, flow cytometry, viability assays, metabolic profiling and in vivo infection or tumor models.
Does the tissue microenvironment affect activated T cell autonomous death?
Yes, liver sinusoidal endothelial cells regulate CD8 T cell tolerance induction and tumors can mediate T cell trafficking and exclusion, showing that the microenvironment modulates this process.
Conclusion
GO:0070241, positive regulation of activated T cell autonomous cell death, defines the cell-intrinsic mechanisms that increase the death of activated T cells. Work on caspase-8, CARD11, mitochondrial arginase-2, glucocorticoid metabolite regeneration and cytokine cues such as TL1A has established that this process is central to immune contraction, tolerance and the prevention of activated T cell hyperaccumulation. Dysregulation of the process is linked to autoimmunity, inflammatory bowel disease, antiviral immunopathology and cancer immunity. Because the process is cell-autonomous, it is well suited to CRISPR-based dissection, and EDITGENE provides the knockout, point-mutation, knock-in, overexpression and screening platforms needed to identify and validate its regulators.
References
- 1. Rocamora-Reverte L et al.. 2017. T-cell autonomous death induced by regeneration of inert glucocorticoid metabolites.. Cell Death Dis 8(7):e2948 PMID: 28726773
- 2. Meng F et al.. 2023. Tumor necrosis factor-like cytokine 1A plays a role in inflammatory bowel disease pathogenesis.. Proc Natl Acad Sci U S A 120(34):e2120771120 PMID: 37579137
- 3. Masle-Farquhar E et al.. 2023. CARD11 gain-of-function mutation drives cell-autonomous accumulation of PD-1(+) ICOS(high) activated T cells, T-follicular, T-regulatory and T-follicular regulatory cells.. Front Immunol 14:1095257 PMID: 36960072
- 4. Schurich A et al.. 2010. Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells.. J Immunol 184(8):4107-14 PMID: 20212092
- 5. Martí i Líndez AA et al.. 2019. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.. JCI Insight 4(24) PMID: 31751318
- 6. Celus W et al.. 2022. Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer.. Cancer Immunol Res 10(1):126-141 PMID: 34815265
- 7. Feng Y et al.. 2019. Caspase-8 restricts antiviral CD8 T cell hyperaccumulation.. Proc Natl Acad Sci U S A 116(30):15170-15177 PMID: 31285326
- 8. Dang JL et al.. 2026. Tumoral AMER1 driven dopamine synthesis triggers cancer cell pyroptosis and licenses CD8(+) T cell immunity in colorectal cancer.. Cancer Lett 659:218772 PMID: 42546913
